| L-MM 0697.10 | Amiodarone N-Oxide Hydrochloride | 100mg |
| L-MM 0548.05 | Imp. E (EP) as Dihydrochloride: Biphenyl-4,4'- diamine Dihydrochloride (Benzidine Dihydrochloride) | 100mg |
| L-MM 0548.04 | Imp. D (EP): 1,2-Diphenyldiazene | 100mg |
| L-MM 0548.03 | Imp. C (EP): 1,2-Diphenyldiazane (1,2-Diphenylhydrazine) | 100mg |
| L-MM 0548.02 | Imp. B (EP): 4-Butyl-4-hydroxy-1,2- diphenylpyrazolidine-3,5-dione | 50mg |
| L-MM 0548.01 | Imp. A (EP): (2RS)-2-[(1,2-Diphenyldiazanyl)- carbonyl]hexanoic Acid | 100mg |
| L-MM 0548.00 | Phenylbutazone | 500mg |
| MM 2500.00-1 | Albendazole;Imp.E(EP):Methyl (1H-Benzimidazol-2-yl)carbamate (Carbendazim) | 100mg |
| MM 2500.00-2 | Fenbendazole;Imp. A (EP): Methyl (1H-Benzimidazol-2-yl)carbamate (Carbendazim) | 100mg |
| MM 2500.00-3 | Carbendazim | 100mg |
| MM 1147.00-1 | Pseudoephedrine Hydrochloride;Imp. A (EP) as Sulphate: Ephedrine Sulphate [Drug Precursor] | 250mg |
| MM 1147.00-2 | Ephedrine Sulphate;Ephedrine Sulphate [Drug Precursor] | 250mg |
| MM 1131.00-1 | Mequinol | 500mg |
| MM 1131.00-2 | Guaiacol;Imp. G (EP): 4-Methoxyphenol (Mequinol) | 500mg |
| MM 1119.00-1 | Testosterone Isocaproate;Imp. F (EP): Testosterone Enantate | 100mg |
| MM 1119.00-2 | Testosterone Enantate | 100mg |
| MM 1114.00-1 | Dexchlorpheniramine Maleate | 100mg |
| MM 1114.00-2 | Brompheniramine Maleate;Imp. B (EP) as Maleate: Dexchlorpheniramine Maleate | 100mg |
| MM 0973.00-1 | Norfenefrine Hydrochloride | 500mg |
| MM 0973.00-2 | Etilefrine Hydrochloride;Imp. C (EP) as Hydrochloride: (1RS)-2-Amino- 1-(3-hydroxyphenyl)ethanol Hydrochloride (Norfenefrine Hydrochloride) | 500mg |
| MM 0958.04-1 | Trimeprazine Tartrate;Trimeprazine Sulphone N-Oxide Hydrochloride (Oxomemazine N-Oxide Hydrochloride) | 100mg |
| MM 0958.04-2 | Oxomemazine;Oxomemazine N-Oxide Hydrochloride (Trimeprazine Sulphone N-Oxide Hydrochloride) | 100mg |
| MM 0958.02-1 | Trimeprazine Tartrate;Trimeprazine Sulphoxide Hydrochloride | 100mg |
| MM 0958.02-2 | Oxomemazine;Trimeprazine Sulphoxide Hydrochloride | 100mg |
| MM 0958.00-1 | Trimeprazine Tartrate | 500mg |
| MM 0958.00-2 | Oxomemazine;Trimeprazine Tartrate | 500mg |
| MM 0957.00-1 | Trimeprazine Tartrate;Trimeprazine Sulphone (Oxomemazine) | 100mg |
| MM 0957.00-2 | Oxomemazine | 100mg |
| MM 0943.02-1 | Nitrofural;Imp. B (EP): (5-Nitrofuran-2-yl)methylene Diacetate | 100mg |
| MM 0943.02-2 | Nifuroxazide;Imp. C (EP): (5-Nitrofuran-2-yl)methylidene Diacetate ((5-Nitrofuran-2-yl)methylene Diacetate) | 100mg |
| MM 0942.09-1 | Glipizide;Imp. I (EP): N-(Cyclohexylcarbamoyl)- 4-[2-[(cyclohexylcarbamoyl)amino]- ethyl]benzenesulphonamide | 100mg |
| MM 0942.09-2 | Glibenclamide;Imp. C (Pharmeuropa): 1-[[4-[2-[(Cyclohexylcarbamoyl)amino]- ethyl]phenyl]sulfonyl]-3-cyclohexylurea (N-(Cyclohexylcarbamoyl)-4-[2-[(cyc | 100mg |
| MM 0928.00-1 | Oxaliplatin;Imp. A (EP) as Dihydrate: Ethanedioic Acid Dihydrate (Oxalic Acid Dihydrate) | 500mg |
| MM 0928.00-2 | Oxalic Acid Dihydrate | 500mg |
| MM 0915.01-1 | Niflumic Acid;Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid (2-Chloronicotinic Acid) | 100mg |
| MM 0915.01-2 | Flunixin Meglumine;Imp. A (EP): 2-Chloropyridine-3-carboxylic Acid | 100mg |
| MM 0899.00-1 | Allobarbital;Allobarbital [Controlled Substance] | 100mg |
| MM 0899.00-2 | Butalbital;5,5-Diallybarbituric acid (Allobarbital) [Controlled Substance] | 100mg |
| MM 0897.00-1 | Testosterone Propionate | 100mg |
| MM 0897.00-2 | Testosterone Isocaproate;Imp. C (EP): Testosterone Propionate | 100mg |
| MM 0883.00-1 | Sulfaguanidine | 100mg |
| MM 0883.00-2 | Sulfadimidine;Imp. C (Pharmeuropa): (4-Aminophenylsulphonyl)- guanidine (Sulfaguanidine) | 100mg |
| MM 0864.00-1 | Pharmaceutical impurities;Imp. H (EP): 17b-Hydroxyandrosta-1,4-dien-3-one (Boldenone) | 100mg |
| MM 0864.00-2 | Boldenone | 100mg |
| MM 0863.08-1 | Testosterone Isocaproate;Imp. E (EP): 3-Oxoandrost-4-en-17b-yl Hexanoate (Testosterone Caproate) | 100mg |
| MM 0863.08-2 | Testosterone Enantate;Imp. B (EP): 3-Oxoandrost-4-en-17b-yl Hexanoate (Testosterone Caproate) | 100mg |
| MM 0863.07-1 | Pharmaceutical impurities;Imp. B (EP): 3-Oxoandrost-4-en-17b-yl 2-Methyl- propanoate (Testosterone Isobutyrate) | 100mg |
| MM 0863.07-2 | Testosterone Isocaproate;Imp. D (EP): 3-Oxoandrost-4-en-17b-yl 2- Methylpropanoate (Testosterone Isobutyrate) | 100mg |
| MM 0826.00-1 | Perazine Dimalonate;Perphenazine | 100mg |
| MM 0826.00-2 | Fluphenazine Dihydrochloride;Imp. E (EP): 2-[4-[3-[2-Chloro-10H-phenothiazin- 10-yl]propyl]piperazin-1-yl]ethanol (Perphenazine) | 100mg |
| MM 0811.01-1 | Cefradine;Imp. A (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-Aminodeacetoxycephalosporanic Acid | 100mg |
| MM 0811.01-2 | Cefetamet;7-Aminodesacetoxycephalosporanic Acid | 100mg |
| MM 0811.01-3 | Cefalexin Monohydrate;Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-Aminodesacetoxycephalosporanic Aci | 100mg |
| MM 0811.01-4 | Cefadroxil Monohydrate;Imp. B (EP): (6R,7R)-7-Amino-3-methyl-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (7-ADCA; 7-Aminodesacetoxycephalospor | 100mg |
| MM 0795.00-1 | Benzyl Alcohol | 500mg |
| MM 0795.00-2 | Benzalkonium Chloride;Imp. A (EP): Benzyl Alcohol | 500mg |
| MM 0792.03-1 | Sertraline Hydrochloride;Imp. E (EP) as Racemate: Hydroxyphenylacetic Acid (Mandelic Acid) | 100mg |
| MM 0792.03-2 | Hexylresorcinol;Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid) | 100mg |
| MM 0792.03-3 | Glycopyrronium Bromide;Imp. C (EP): (2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid) | 100mg |
| MM 0783.09-1 | Trospium Chloride;Imp. A (EP): Hydroxydiphenylacetic Acid (Benzilic Acid) | 100mg |
| MM 0783.09-2 | Quinuclidinyl Benzilate;Benzilic Acid | 100mg |
| MM 0783.09-3 | Pipenzolate Bromide;Benzilic Acid | 100mg |
| MM 0749.05-1 | Lamivudine;Imp. E (EP): 4-Aminopyrimidin-2(1H)-one(Cytosine) | 100mg |
| MM 0749.05-2 | Gabapentin;Imp. A (EP): 4-Aminopyrimidin-2(1H)-one (Cytosine) | 100mg |
| MM 0682.00-1 | Orphenadrine Hydrochloride;Imp. E (EP) as Sodium Salt Monohydrate: Cloxacillin Sodium Monohydrate | 500mg |
| MM 0682.00-2 | Cloxacillin Sodium;Cloxacillin Sodium Monohydrate | 500mg |
| MM 0679.00-1 | Butylhydroxytoluene | 500mg |
| MM 0679.00-2 | Butylhydroxytoluene | 500mg |
| MM 0678.03-1 | Sodium Cyclamate;Imp. C (EP): Cyclohexanamine | 100mg |
| MM 0678.03-2 | Glipizide;Imp. B (EP): Cyclohexanamine | 100mg |
| MM 0672.00-1 | Oxycodone Hydrochloride;Oxycodone Hydrochloride [Controlled Substance] | 100mg |
| MM 0672.00-2 | Hydrochlorothiazide;Imp. D (EP) as Hydrochloride: 4,5a-Epoxy-14- hydroxy-3-methoxy-17-methylmorphinan-6- one Hydrochloride (Oxycodone Hydrochloride) | 100mg |
| MM 0660.01-1 | Norethisterone;Imp. B (EP): Estr-4-ene-3,17-dione (Norandrostenedione) | 100mg |
| MM 0660.01-2 | Nandrolone;19-Norandrost-4-ene-3,17-dione (Estr-4-ene-3,17-dione) | 100mg |
| MM 0660.00-1 | Nandrolone Decanoate;Imp. D (EP): 17β-Hydroxyestr-4-en-3-one (Nandrolone) | 250mg |
| MM 0660.00-2 | Nandrolone | 250mg |
| MM 0656.00-1 | Selegiline Hydrochloride;Imp. C (EP) as Hydrochloride: (1RS, 2SR)-2- Amino-1-phenylpropan-1-ol Hydrochloride (Phenylpropanolamine Hydrochloride) | 500mg |
| MM 0656.00-2 | Phenylpropanolamine Hydrochloride;Phenylpropanolamine Hydrochloride [Drug Precursor] | 500mg |
| MM 0652.00-1 | Pseudoephedrine Hydrochloride;Imp. A (EP) as Hydrochloride: Ephedrine Hydrochloride [Drug Precursor] | 500mg |
| MM 0652.00-2 | Ephedrine Hydrochloride;Ephedrine Hydrochloride [Drug Precursor] | 500mg |
| MM 0647.01-1 | Glimepiride;Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N- [2-(4-sulphamoylphenyl)ethyl]-2,3-dihydro-1Hpyrrole- 1-carboxamide (Glimepiride Sulphonamide) | 100mg |
| MM 0647.01-2 | Glimepiride;Imp. B (EP): 3-Ethyl-4-methyl-2-oxo-N- [2-(4-sulphamoylphenyl)ethyl]-2,3-dihydro-1Hpyrrole- 1-carboxamide (Glimepiride Sulphonamide) | 100mg |
| MM 0640.00-1 | Diphenhydramine Hydrochloride;Imp. C (EP) as Hydrochloride: 2-[(RS)- (4-Bromophenyl)phenylmethoxy]-N,Ndimethylethanamine Hydrochloride (Bromazine Hydrochloride) | 100mg |
| MM 0640.00-2 | Diltiazem Hydrochloride;Imp. H (EP) as Hydrochloride: 2-[(RS)-(4- Bromophenyl)(phenyl)methoxy]-N,N-dimethylethanamine Hydrochloride (4-Bromodiphenhydramine Hydr | 100mg |
| MM 0636.00-1 | Demeclocycline Hydrochloride | 250mg |
| MM 0636.00-2 | Chlortetracycline Hydrochloride;Imp. B (EP) as Hydrochloride: Demeclocycline Hydrochloride | 250mg |
| MM 0635.00-1 | Medroxyprogesterone Acetate;Imp. B (EP):17-Hydroxy-6a-methylpregn-4-ene-3,20-dione (Medroxyprogesterone) | 100mg |
| MM 0635.00-2 | Medroxyprogesterone | 100mg |
| MM 0634.00-1 | Tyrosine | 100mg |
| MM 0634.00-2 | Levodopa;Imp. B (EP): (2S)-2-Amino-3-(4-hydroxyphenyl) propanoic Acid (Tyrosine) | 100mg |
| MM 0630.08-1 | Phenytoin Sodium;Imp. F (EP): 5-(4-Methylphenyl)-5- phenylimidazolidine-2,4-dione | 100mg |
| MM 0630.08-2 | Phenytoin;Imp. F (EP): 5-(4-Methylphenyl)-5-phenylimidazolidine- 2,4-dione | 100mg |
| MM 0630.07-1 | Phenytoin Sodium;1-Methyl-5,5-diphenylimidazolidine-2,4-dione | 100mg |
| MM 0630.07-2 | Phenytoin;1-Methyl-5,5-diphenylimidazolidine-2,4-dione | 100mg |
| MM 0630.04-1 | Phenytoin Sodium;Imp. C (EP): Amino(diphenyl)acetic Acid (2,2-Diphenylglycine) | 100mg |
| MM 0630.04-2 | Phenytoin;Imp. C (EP): Amino(diphenyl)acetic Acid (2,2-Diphenylglycine) | 100mg |
| MM 0630.03-1 | Phenytoin Sodium;5-(4-Methylphenyl)hydantoin | 100mg |
| MM 0630.03-2 | Phenytoin;5-(4-Methylphenyl)hydantoin | 100mg |
| MM 0630.02-1 | Phenytoin Sodium;Imp. B (EP): Diphenylethanedione (Benzil) | 100mg |
| MM 0630.02-2 | Phenytoin;Imp. B (EP): Diphenylethanedione (Benzil) | 100mg |
| MM 0630.01-1 | Pipenzolate Bromide;Diphenylmethanone (Benzophenone) | 100mg |
| MM 0630.01-2 | Phenytoin Sodium;Imp. A (EP): Diphenylmethanone (Benzophenone) | 100mg |
| MM 0630.01-3 | Phenytoin;Imp. A (EP): Diphenylmethanone (Benzophenone) | 100mg |
| MM 0630.01-4 | Hydrochlorothiazide;Imp. H (EP): Diphenylmethanone (Benzophenone) | 100mg |
| MM 0630.01-5 | Diphenylpyraline Hydrochloride;Diphenylmethanone (Benzophenone) | 100mg |
| MM 0630.01-6 | Diphenhydramine Hydrochloride;Imp. E (EP): Diphenylmethanone (Benzophenone) | 100mg |
| MM 0614.02-1 | Adrenaline Tartrate;L-Adrenaline | 500mg |
| MM 0614.02-2 | Noradrenaline Tartrate;Imp. A (EP): Adrenaline (L-Adrenaline) | 500mg |
| MM 0603.00-1 | Theophylline-Ethylenediamine;Imp. F (EP): Etofylline | 500mg |
| MM 0603.00-2 | Theophylline;Imp. F (EP): Etofylline | 500mg |
| MM 0603.00-3 | Etofylline | 500mg |
| MM 0603.00-4 | Diprophylline;Imp. C (EP): 7-(2-Hydroxyethyl)-1,3-dimethyl- 3,7-dihydro-1H-purine-2,6-dione (Etofylline) | 500mg |
| MM 0601.03-1 | Tropicamide;Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid) | 100mg |
| MM 0601.03-2 | Ipratropium Bromide;Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (dl-Tropic Acid) | 100mg |
| MM 0601.03-3 | Hyoscyamine Sulphate;Imp. A (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) | 100mg |
| MM 0601.03-4 | Hyoscine Butylbromide;Imp. D (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) | 100mg |
| MM 0601.03-5 | Hyoscine Butylbromide;Imp. B (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (DL-Tropic Acid; Tropic Acid) | 100mg |
| MM 0601.03-6 | Atropine;Imp. C (EP): (2RS)-3-Hydroxy-2-phenylpropanoic Acid (Tropic Acid) | 100mg |
| MM 0599.14-1 | Modafinil;Bis(diphenylmethyl) Ether | 50mg |
| MM 0599.14-2 | Diltiazem Hydrochloride;Imp. K (EP): [Oxybis(methanetriyl)]tetrabenzene (Bis(diphenylmethyl) Ether) | 50mg |
| MM 0593.03-1 | Lamivudine;Imp. F (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil) | 100mg |
| MM 0593.03-2 | Fluorouracil;Imp. C (EP): Pyrimidine-2,4(1H,3H)-dione (Uracil) | 100mg |
| MM 0593.00-1 | Fluorouracil | 500mg |
| MM 0593.00-2 | Fluconazole;Imp. A (EP): 5-Fluoropyrimidine-2,4(1H,3H)-dione (Fluorouracil) | 500mg |
| MM 0589.00-1 | Imidocarb Dipropionate;Imp. A (EP) as Hydrochloride: 3-(10,11-Dihydro- 5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1- amine Hydrochloride (Desipramine Hydrochlo | 250mg |
| MM 0589.00-2 | Desipramine Hydrochloride | 250mg |
| MM 0581.00-1 | Sulfamerazine | 500mg |
| MM 0581.00-2 | Sulfadimidine;Imp. A (Pharmeuropa): 4-Amino-N-(4-methyl-2- pyrimidyl)benzenesulphonamide (Sulfamerazine) | 500mg |
| MM 0579.00-1 | Sulfadimidine;Imp. E (Pharmeuropa): N-[(4-Aminophenyl)sulfonyl]- acetamide (Sulfacetamide) | 500mg |
| MM 0579.00-2 | Sulfacetamide | 500mg |
| MM 0577.00-1 | Theophylline-Ethylenediamine;Imp. G (EP): Theobromine | 500mg |
| MM 0577.00-2 | Theobromine | 500mg |
| MM 0577.00-3 | Pentoxifylline;Imp. A (EP): Theobromine | 500mg |
| MM 0577.00-4 | Butylhydroxytoluene;Imp. D (EP): Theobromine | 500mg |
| MM 0576.00-1 | Isoxsuprine Hydrochloride | 500mg |
| MM 0576.00-2 | Isosorbide Mononitrate | 500mg |
| MM 0566.00-1 | Alanine | 500mg |
| MM 0566.00-2 | Aspartic Acid;Imp. D (Pharmeuropa): (S)-2-Aminopropanoic Acid (Alanine) | 500mg |
| MM 0565.00-1 | Pharmaceutical impurities;Imp. F (EP): 17b-Hydroxy-5a-androstan-3-one (Androstanolone, Stanolone) | 250mg |
| MM 0565.00-2 | Androstanolone | 250mg |
| MM 0553.00-1 | Nicotinic Acid | 500mg |
| MM 0553.00-2 | Methyl Nicotinate;Imp. A (EP): Nicotinic Acid | 500mg |
| MM 0553.00-3 | Benzyl Nicotinate;Nicotinic Acid | 500mg |
| MM 0549.00-1 | Nicotinic Acid;Methyl Nicotinate | 500mg |
| MM 0549.00-2 | Methyl Nicotinate;Methyl Nicotinate | 500mg |
| MM 0546.00-1 | Hyoscyamine Sulphate;Imp. D (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate | 500mg |
| MM 0546.00-2 | Hyoscine Butylbromide;Hyoscine Hydrobromide Trihydrate | 500mg |
| MM 0546.00-3 | Hyoscine Butylbromide;Imp. A (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate | 500mg |
| MM 0546.00-4 | Atropine;Imp. F (EP) as Hydrobromide Trihydrate: Hyoscine Hydrobromide Trihydrate | 500mg |
| MM 0541.00-1 | Miconazole Nitrate;Imp. D (EP) as Nitrate: 1-[(2RS)-2-[(2,6-Dichlorobenzyl)oxy]- 2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate (Isoconazole Nitrate) | 100mg |
| MM 0541.00-2 | Isoconazol Nitrate | 100mg |
| MM 0534.03-1 | Zidovudine;Thymidine | 100mg |
| MM 0534.03-2 | Stavudine;Imp. C (EP): 1-(2-Deoxy-b-D-erythro-pentofuranosyl)- 5-methylpyrimidine-2,4(1H,3H)-dione (Thymidine) | 100mg |
| MM 0534.01-1 | Zidovudine;Imp. C (EP): 5-Methylpyrimidine-2,4(1H,3H)dione (Thymine) | 100mg |
| MM 0534.01-2 | Stavudine;Imp. A (EP): 5-Methylpyrimidine-2,4(1H,3H)-dione (Thymine) | 100mg |
| MM 0534.00-1 | Zidovudine;Imp. A (EP): 1-[(2R,5S)-5-(Hydroxymethyl)-2,5- dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione (Stavudine) | 100mg |
| MM 0534.00-2 | Stavudine | 100mg |
| MM 0532.09-1 | Megestrol Acetate;Imp. K (Pharmeuropa): 3,20-Dioxopregn-4-en-17-yl Acetate | 100mg |
| MM 0532.09-2 | Medroxyprogesterone Acetate;Imp. H (EP): 3,20-Dioxopregn-4-en-17-yl Acetate (Hydroxyprogesterone Acetate) | 100mg |
| MM 0532.07-1 | Megestrol Acetate | 250mg |
| MM 0532.07-2 | Medroxyprogesterone Acetate;Imp. G (EP): 6-Methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate (Megestrol Acetate) | 250mg |
| MM 0532.00-1 | Megestrol Acetate;Imp. A (EP): 6a-Methyl-3,20-dioxopregn-4-en-17-yl Acetate (Medroxyprogesterone Acetate) | 100mg |
| MM 0532.00-2 | Medroxyprogesterone Acetate | 100mg |
| MM 0524.00-1 | Miconazole Nitrate;Imp. B (EP) as Nitrate: 1-[(2RS)-2-[(4-Chlorobenzyl)oxy]- 2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate (Econazole Nitrate) | 500mg |
| MM 0524.00-2 | Econazole Nitrate | 500mg |
| MM 0518.02-1 | Oxeladin Hydrogen Citrate;Imp. B (EP): Methyl [5-(Phenylsulphonyl)- 1H-benzimidazol-2-yl]carbamate (Fenbendazole Sulphone) | 100mg |
| MM 0518.02-2 | Fenbendazole;Fenbendazole Sulphone | 100mg |
| MM 0502.00-1 | Isosorbide Mononitrate | 500mg |
| MM 0502.00-2 | Isosorbide Dinitrate;Imp. C (EP): Isosorbide Mononitrate (Isosorbide 5-Nitrate) | 500mg |
| MM 0498.00-1 | Propyl Parahydroxybenzoate;Imp. C (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate) | 500mg |
| MM 0498.00-2 | Methyl Parahydroxybenzoate;Imp. B (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate) | 500mg |
| MM 0498.00-3 | Ethyl Parahydroxybenzoate | 500mg |
| MM 0498.00-4 | Butyl Parahydroxybenzoate;Imp. C (EP): Ethyl 4-Hydroxybenzoate (Ethyl Parahydroxybenzoate) | 500mg |
| MM 0496.00-1 | Propyl Parahydroxybenzoate;Imp. D (EP): Butyl 4-Hydroxybenzoate (Butyl Parahydroxybenzoate) | 500mg |
| MM 0496.00-2 | Methyl Parahydroxybenzoate;Imp. D (EP): Butyl 4-Hydroxybenzoate (Butyl Parahydroxybenzoate) | 500mg |
| MM 0496.00-3 | Ethyl Parahydroxybenzoate;Imp. D (EP): Butyl 4-Hydroxybenzoate (Butyl Parahydroxybenzoate) | 500mg |
| MM 0496.00-4 | Butyl Parahydroxybenzoate | 500mg |
| MM 0494.03-1 | Butylhydroxytoluene;Imp. C (EP): 1,3,9-Trimethyl-3,9-dihydro- 1H-purine-2,6-dione (Isocaffeine) | 50mg |
| MM 0494.03-2 | Caffeine;Imp. C (EP): 1,3,9-Trimethyl-3,9-dihydro- 1H-purine-2,6-dione (Isocaffeine) | 50mg |
| MM 0494.00-1 | Theophylline-Ethylenediamine;Imp. A (EP): Caffeine | 500mg |